Astera Labs, Inc. $ALAB Position Boosted by Hsbc Holdings PLC

Hsbc Holdings PLC increased its position in Astera Labs, Inc. (NASDAQ:ALAB) by 128.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 83,721 shares of the company’s stock after purchasing an additional 47,081 shares during the period. Hsbc Holdings PLC’s holdings in Astera Labs were worth $14,126,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Atreides Management LP lifted its holdings in Astera Labs by 2,496.6% during the 4th quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock worth $268,038,000 after buying an additional 1,549,144 shares during the last quarter. Amundi grew its position in shares of Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC bought a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $209,599,000. BNP Paribas Financial Markets increased its holdings in shares of Astera Labs by 577.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after acquiring an additional 960,899 shares during the last quarter. Finally, Artisan Partners Limited Partnership acquired a new stake in shares of Astera Labs during the 4th quarter valued at approximately $148,980,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ALAB shares. Needham & Company LLC raised their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Roth Mkm reiterated a “buy” rating and set a $275.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Evercore reissued an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. Susquehanna boosted their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Finally, TD Cowen increased their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research note on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $254.75.

Insider Buying and Selling

In related news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director directly owned 319,863 shares in the company, valued at $34,420,457.43. The trade was a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161,256 shares of company stock valued at $459,844,296 in the last three months. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs Stock Down 0.5%

Shares of NASDAQ:ALAB opened at $398.00 on Friday. The company’s 50-day moving average price is $284.80 and its 200 day moving average price is $194.71. The company has a market cap of $68.22 billion, a PE ratio of 268.92, a P/E/G ratio of 4.59 and a beta of 3.95. Astera Labs, Inc. has a fifty-two week low of $85.85 and a fifty-two week high of $440.99.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.